67 - Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids as Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease

Autor: Kekre, Natasha, Kim, Haesook T., Ho, Vincent T., Guo, Yikun, Mahmood, Umair, Belatreche, Wafae, Koreth, John, Armand, Philippe, Nikiforow, Sarah, Alyea, Edwin P., Nageshwar, Prashant, Glotzbecker, Brett, El-Jawahri, Areej R., Soiffer, Robert J., Antin, Joseph H., Chen, Yi-Bin, Cutler, Corey
Zdroj: In Biology of Blood and Marrow Transplantation March 2018 24(3) Supplement:S81-S81
Databáze: ScienceDirect